We are thrilled to announce that Seqera is joining forces with tinybio, a NYC-based tech-bio start-up known for its AI-integrated scientific tools focused on executing pipelines and analyses via natural language. We are happy to welcome the tinybio team and community into the Seqera family.

我们很高兴地宣布，Sekera正在与tinybio联手，tinybio是一家总部位于纽约的科技生物初创公司，以其人工智能集成科学工具而闻名，该工具专注于通过自然语言执行管道和分析。我们很高兴欢迎tinybio团队和社区加入Sekera大家庭。

Scientists spend a significant proportion of their time transforming and structuring data for analysis. In fact, a lessons-learned piece on the COVID-19 pandemic underscored how issues in data analysis and study design can significantly impact scientific breakthroughs. As biological data continues to grow exponentially, there is an urgent need to manage large-scale data more rapidly for accelerated scientific breakthroughs.

科学家花费大量时间转换和构建数据进行分析。事实上，一篇关于新型冠状病毒大流行的经验教训强调了数据分析和研究设计中的问题如何对科学突破产生重大影响。随着生物数据继续呈指数增长，迫切需要更快地管理大规模数据，以加速科学突破。

To achieve this, we are partnering with tinybio to harness the power of GenAI, lowering the barrier for scientists to fully leverage advanced computational tools to achieve their research goals..

为此，我们与 tinybio 合作，利用 GenAI 的力量，降低科学家充分利用先进计算工具实现研究目标的门槛。

tinybio: Specialized ChatGPT for Researchers

tinybio：为研究人员提供的专业ChatGPT

Motivated by challenges faced as researchers experimenting with different bioinformatics packages, Sasha and Vishal founded tinybio in 2022, convinced there had to be a better, easier way to get started with bioinformatics. The initial goal of tinybio was to remove the barrier to entry for running bioinformatics packages, a mission that gained significant momentum with the announcement of ChatGPT in November 2022.

出于研究人员在实验不同的生物信息学软件包时面临的挑战，萨莎和维沙尔于2022年成立了tinybio，他们确信必须有一种更好、更容易的方法来开始生物信息学。tinybio的最初目标是消除运行生物信息学软件包的进入障碍，这项任务随着2022年11月ChatGPT的宣布而获得了巨大的动力。

The tinybio co-founders recognized the potential of leveraging GenAI to empower all scientists to effectively utilize bioinformatics tools, regardless of their experience or research background. Ever since, tinybio has focused on applying GenAI to drive bioinformatics innovation..

tinybio联合创始人认识到利用GenAI的潜力，使所有科学家能够有效利用生物信息学工具，无论他们的经验或研究背景如何。从那以后，tinybio一直专注于应用GenAI来推动生物信息学创新。。

“After seeing the amazing traction around our chat-based pipeline execution and analysis tool, Vishal and I knew that we needed to partner with the leader in bioinformatics pipelines to enable our vision for more open science and to onboard millions more to computational biology. We are truly excited to be joining the Seqera team and contributing to advancing science for everyone through their Nextflow, Wave, MultiQC, and Fusion products,” said Sasha Dagayev, Co-Founder at tinybio..

tinybio联合创始人萨莎·达加耶夫（SashaDagayev）表示：“在看到我们基于聊天的管道执行和分析工具的惊人吸引力后，我和维沙尔知道我们需要与生物信息学管道的领导者合作，以实现我们对更开放科学的愿景，并为数百万计算生物学提供支持。我们非常高兴能够加入Seqera团队，并通过他们的Nextflow、Wave、MultiQC和Fusion产品为每个人的科学进步做出贡献。”。。

tinybio’s authentic and pragmatic approach to leveraging LLMs for bioinformatics is essential in bridging the gap between scientists and advanced computational capabilities to accelerate scientific discovery. By incorporating this technology, we aim to significantly enhance our existing pipelines, containers, and web resources, making high-quality, reproducible bioinformatics tools more accessible to researchers worldwide.

tinybio利用LLM进行生物信息学的真实而实用的方法对于弥合科学家与先进计算能力之间的差距以加速科学发现至关重要。通过整合这项技术，我们的目标是显着增强我们现有的管道，容器和网络资源，使全世界的研究人员更容易获得高质量，可重复的生物信息学工具。

Our goal is to empower the global scientific community with the resources they need to drive innovation and advance our understanding of complex biological systems..

我们的目标是为全球科学界提供推动创新和增进我们对复杂生物系统的理解所需的资源。。

A New Era for AI-Enabled Bioinformatics

人工智能生物信息学的新时代

The biotech and bioinformatics landscape is rapidly evolving, driven in part by technological advances in AI. The ability to analyze massive datasets, identify patterns, and generate predictive models is revolutionizing scientific research. We also believe that AI is a powerful tool to democratize and amplify access to the most sophisticated bioinformatics tools out there.

生物技术和生物信息学领域正在迅速发展，部分原因是人工智能的技术进步。分析海量数据集，识别模式和生成预测模型的能力正在彻底改变科学研究。我们还认为，人工智能是一种强大的工具，可以民主化和扩大对最复杂的生物信息学工具的访问。

By leveraging human-centric AI, we can enable the 10x scientist to translate complex biological data into actionable insights, thereby expediting scientific discovery and innovation..

通过利用以人为中心的人工智能，我们可以使10倍的科学家将复杂的生物学数据转化为可行的见解，从而加速科学发现和创新。。

Our partnership with tinybio represents a significant milestone in our journey to advance science for everyone through software. This collaboration will lower the barrier of entry for a broader range of researchers to utilize bioinformatics tools effectively, facilitating groundbreaking innovations, and transforming the future of genomics..

我们与tinybio的合作代表了我们通过软件为每个人推进科学之旅的一个重要里程碑。这种合作将降低更广泛的研究人员有效利用生物信息学工具的门槛，促进突破性的创新，并改变基因组学的未来。。

“New interaction models with powerful computational platforms are transforming not just how scientists work but also what they discover. By empowering scientists with modern software engineering practices, we are enabling the next generation of innovations in personalized therapeutics, sustainable materials, better drug delivery methodologies, and green chemical and agricultural production.

“具有强大计算平台的新交互模型不仅正在改变科学家的工作方式，而且正在改变他们的发现。通过为科学家提供现代软件工程实践，我们正在实现个性化治疗、可持续材料、更好的药物输送方法以及绿色化学和农业生产方面的下一代创新。

This acquisition marks a significant step towards accelerating scientific discoveries and enabling researchers with better software,” said Evan Floden, CEO at Seqera..

Sekera首席执行官埃文·弗洛登（EvanFloden）表示：“此次收购标志着朝着加速科学发现和为研究人员提供更好的软件迈出了重要的一步。”。。

Enhancing our Open Science Core

增强我们的开放科学核心

Our mission at Seqera is to make science accessible to everyone through software. As research becomes increasingly digitized, there is a critical need to access all available scientific research to make informed R&D decisions and ultimately accelerate the impact on patients. Central to achieving this is Open Science, which ensures reproducibility, validation, and transparency across the scientific community.

我们在Sekera的使命是通过软件让每个人都可以访问科学。随着研究越来越数字化，迫切需要访问所有可用的科学研究，以做出明智的研发决策，并最终加速对患者的影响。实现这一目标的核心是开放科学，它确保了科学界的可重复性，验证性和透明度。

With AI, we want to further enhance our Open Science core, by lowering the barrier of adoption of bioinformatics tools for millions more researchers worldwide, driving more rapid advancements in science and medicine..

通过人工智能，我们希望通过降低全球数百万研究人员采用生物信息学工具的障碍，进一步增强我们的开放科学核心，推动科学和医学的更快发展。。

What’s Next for Seqera and tinybio?

Sekera和tinybio的下一步是什么？

Seqera is excited to collaborate closely with tinybio’s founders Sasha Dagayev and Vishal Patel to further its mission of advancing science for everyone through software. Their expertise will be instrumental in driving the development of community-centric tools on Seqera.io, empowering scientists worldwide to leverage modern software capabilities on demand..

。他们的专业知识将有助于推动Seqera.io上以社区为中心的工具的开发，使全球科学家能够根据需要利用现代软件功能。。

We will first focus on leveraging AI to solve the cold start problem for the next generation of scientists and removing barriers to entry to bioinformatics. Existing powerful frameworks and resources, such as Nextflow, nf-core, and Seqera Pipelines and Containers, have been significantly enhancing the research productivity of bioinformaticians, but come with a steep learning curve that prevents newcomers from getting started fast..

我们将首先关注利用人工智能解决下一代科学家的冷启动问题，并消除进入生物信息学的障碍。现有的强大框架和资源，例如Nextflow，nf core和Sekera管道和容器，已经大大提高了生物信息学家的研究生产力，但伴随着陡峭的学习曲线，阻碍了新手快速入门。。

We want to free the next generation of scientists from wasting time in the nitty-gritty of setting up various bioinformatics packages and infrastructure. We believe future scientists should be able to focus on understanding the “what” and “why” of their analysis, while the “how” is generated for them in an understandable and verifiable way.

我们希望让下一代科学家不再浪费时间建立各种生物信息学软件包和基础设施。我们相信，未来的科学家应该能够专注于理解他们分析的“什么”和“为什么”，而“如何”是以一种可理解和可验证的方式为他们生成的。

Our tools and resources provide already powerful building blocks to enable this, and we cannot wait to bring these new updates to users in the coming months. Stay tuned!.

我们的工具和资源为实现这一目标提供了功能强大的构建块，我们迫不及待地想在未来几个月向用户提供这些新的更新。敬请期待！。

About Seqera

关于Sekera

Seqera is the driving force behind Nextflow, MultiQC, and the Seqera Platform – the modern biotech stack. Seqera empowers scientists to solve today’s most complex and essential challenges; from pioneering innovative therapeutics to unveiling the secrets of our universe.

Sekera是Nextflow、MultiQC和Sekera平台（现代生物技术堆栈）背后的驱动力。Sekera使科学家能够解决当今最复杂和最基本的挑战；从开创创新疗法到揭示我们宇宙的秘密。

Across personalized immunogenic vaccines and new diagnostics, our customers are performing the most critical work on this planet. We believe in a future in which scientific tools and open datasets combine to deliver incredible outcomes.

通过个性化免疫原性疫苗和新诊断，我们的客户正在执行这个星球上最关键的工作。我们相信，在未来，科学工具和开放数据集相结合，将产生令人难以置信的结果。

About tinybio

关于tinybio

tinybio is a New York City-based startup focused on the application of generally available generative AI technologies to help bioinformaticians and researchers. It was started by Sasha Dagayev and Vishal Patel in 2022. To date, the company has helped thousands of researchers to resolve hundreds of thousands of bioinformatics issues..

tinybio是一家总部位于纽约市的初创公司，专注于应用普遍可用的生成人工智能技术来帮助生物信息学家和研究人员。它由萨沙·达加耶夫和维沙尔·帕特尔于2022年创办。迄今为止，该公司已帮助数千名研究人员解决了数十万个生物信息学问题。。

Originally announced August 6th, 2024

最初于2024年8月6日宣布

TagsChatGPT Evan Floden Health IT Acquisitions Healthcare M&A Sasha Dagayev Seqera tinybio Vishal Patel

TagsChatGPT Evan Floden Health IT收购医疗保健并购Sasha Dagayev Sekera tinybio Vishal Patel

Get Fresh Healthcare & IT Stories Delivered Daily

每天提供新鲜的医疗保健和IT故事

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻稿的healthcare&HealthIT同行。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不出售或泄露您的联系信息